text

Big pharma turns to AI to speed drug discovery, GSK signs deal

Theworld'sleadingdrugcompaniesareturningtoartificialintelligencetoimprovethehit-and-missbusinessoffindingnewmedicines,withGlaxoSmithKlineunveilinganew$43million